Age-related macular degeneration (AMD) is a leading cause of vision loss among older adults, affecting millions of people worldwide. Central to the fight against this disease have been two significant clinical trials, the Anti-VEGF Antibody for the Treatment of Predominantly Classic Choroidal Neovascularization in Age-Related Macular Degeneration (ANCHOR) and the Minimally Classic/Occult Trial of the […]